The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era.
Ofer AmramSolmaz AmiriVictoria PanwalaRobert LutzPaul J JoudreyMaria Eugenia SociásPublished in: The American journal of drug and alcohol abuse (2021)
Despite a near-doubling of take-home methadone doses during the COVID-19 exemption period, the increase in take-home doses was not associated with negative treatment outcomes in methadone-adherent clients.